On the morning his insider trading trial was slated to begin in U.S. District Court, a San Diego man pleaded guilty to conspiracy, with his plea coming just days after his co-defendant was convicted of the same charge by a federal jury.
Stockbroker Paul Rampoldi, 50, of San Diego was found guilty Friday after the federal trial, and his client, Scott Blythe, 53, pleaded guilty Monday in the case, which involved an illegal trade based on an insider tip about the 2012 merger of San Diego-based Ardea Bioscienses with multinational pharmaceutical company AstraZeneca.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn